Page 20 - Layout 1
P. 20

DIABETES AND
                    OBESITY



        (continued from page 19)

        recommends aiming for an HbA1c <6.5 prior to conception (5),
        while the Endocrine Society recommends an HbA1c level “as close
        to normal as possible” without causing undue hypoglycemia (6).
        Particularly in women with type 2 diabetes who may have a high
        bMI, weight loss and associated improvements in insulin sensitivity
        may help improve ovulation and conception rates (14). Women
        with type 1 diabetes who have microvascular disease have lowered
        overall fertility rates; however, improved long-term glycemic con-
        trol and prevention of end organ damage is associated with an im-
        provement in observed fertility rates (33).



        Key Points:
        •  Menstrual abnormalities, oligomenorrhea, and PCOS are
           common in women with diabetes.
        •  There is controversy as to whether women with type 1 diabetes
           may experience an earlier age at menopause.
        •  Preconception glycemic optimization is critical in decreasing t
           he risk of pregnancy loss and diabetic embryopathy.


        References
        1.    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence
           of diabetes: estimates for the year 2000 and projections for
           2030. diabetes Care. 2004;27(5):1047-53.
        2.    Writing  Group  for  the  SfdiYSG,  dabelea  d,  bell  RA,
           d'Agostino Rb, Jr., Imperatore G, Johansen JM, et al. Incidence
           of  diabetes  in  youth  in  the  United  States.  JAMA.
           2007;297(24):2716-24.
        3.    Kitzmiller Jl, Wallerstein R, Correa A, Kwan S. Preconception  JS. Menstrual cycle differences between women with type 1 di-
           care for women with diabetes and prevention of major con-  abetes  and  women  without  diabetes.  diabetes  Care.
           genital malformations. birth defects Res A Clin Mol Teratol.  2003;26(4):1016-21.
           2010;88(10):791-803.                                8.    Sim SY, Chin Sl, Tan Jl, brown SJ, Cussons AJ, Stuckey bG.
        4.    Persson M, Norman M, Hanson U. Obstetric and perinatal out-  Polycystic ovary syndrome in type 2 diabetes: does it predict a
           comes in type 1 diabetic pregnancies: A large, population-based  more severe phenotype? Fertil Steril. 2016;106(5):1258-63.
           study. diabetes Care. 2009;32(11):2005-9.           9.    Gaete X, vivanco M, Eyzaguirre FC, lopez P, Rhumie HK,
        5.    American diabetes A. 13. Management of diabetes in Preg-  Unanue N, et al. Menstrual cycle irregularities and their rela-
           nancy: Standards of Medical Care in diabetes-2018. diabetes  tionship with HbA1c and insulin dose in adolescents with type
           Care. 2018;41(Suppl 1):S137-S43.                       1 diabetes mellitus. Fertil Steril. 2010;94(5):1822-6.
        6.    blumer I, Hadar E, Hadden dR, Jovanovic l, Mestman JH,  10.  Solomon CG, Hu Fb, dunaif A, Rich-Edwards J, Willett WC,
           Murad MH, et al. diabetes and pregnancy: an endocrine society  Hunter dJ, et al. long or highly irregular menstrual cycles as a
           clinical  practice  guideline.  J  Clin  Endocrinol  Metab.  marker  for  risk  of  type  2  diabetes  mellitus.  JAMA.
           2013;98(11):4227-49.                                   2001;286(19):2421-6.
        7.    Strotmeyer ES, Steenkiste AR, Foley TP, Jr., berga Sl, dorman  11.  lizneva d, Suturina l, Walker W, brakta S, Gavrilova-Jordan l,


         20  San Antonio Medicine   •  December  2018
   15   16   17   18   19   20   21   22   23   24   25